Dyfyniad APA

Singh, S., Gleason, C., Fang, M., Laimon, Y., Khivansara, V., Xie, S., . . . Oser, M. (2024). Cyclin A/B RxL macrocyclic inhibitors to treat cancers with high E2F activity.

Dyfyniad Arddull Chicago

Singh, S., et al. Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity. 2024.

Dyfyniad MLA

Singh, S., et al. Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity. 2024.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.